Management of critically ill cancer patients. Expert consensus statement of the “Intensive Care for Hematology and Oncology Patients” (iCHOP) Working Group of the German Society of Hematology and Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN)

Cancer remains a leading global cause of death, with critically ill cancer patients constituting a substantial proportion of ICU admissions. Historically restrictive ICU admission policies have shifted due to advances in oncology and critical care, leading to declining mortality. However, managing critically ill cancer patients remains complex, requiring collaboration between hematologists/oncologists and intensivists. Emerging evidence on risk assessment, organ support, and tailored critical care underscores the need for updated guidance. This consensus statement provides evidence-based, multidisciplinary recommendations to standardize best practices while allowing for individualized care, aiming to improve survival and quality of life in this high-risk population.